FLI1 and Ewing sarcoma: The new models may help identify small molecule inhibitors that act directly on EWSR1::FLI1 fusion proteins or other genetic vulnerabilities within the altered epigenome and transcriptome, potentially contributing to a better understanding of Ewing sarcoma tumorigenesis.